AZN Stock Summary and Trading Ideas (Astrazeneca PLC - American Depositary Shares | NASDAQ:AZN)

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Astrazeneca PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AZN.

As of December 19, 2025, AZN stock price climbed to $91.36 with 7,037,335 million shares trading.

AZN has a beta of 0.32, meaning it tends to be less sensitive to market movements. AZN has a correlation of 0.05 to the broad based SPY ETF.

AZN has a market cap of $283.05 billion. This is considered a Mega Cap stock.

Last quarter Astrazeneca PLC - American Depositary Shares reported $15 billion in Revenue and $1.19 earnings per share. This beat revenue expectation by $386 million and exceeded earnings estimates by $.05.

In the last 3 years, AZN traded as high as $94.02 and as low as $60.47.

The top ETF exchange traded funds that AZN belongs to (by Net Assets): QQQ, QQQM, PVAL, CGGO, TQQQ.

AZN has outperformed the market in the last year with a price return of +44.2% while the SPY ETF gained +18.1%. AZN has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +19.8% and +1.3%, respectively, while the SPY returned +2.8% and -0.5%, respectively.

AZN support price is $89.43 and resistance is $91.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AZN shares will trade within this expected range on the day.